Pharmacists in Warroad, MN Accepting Medicare
1 Pharmacists found. Showing 1 - 1
 Dr. James R. Thompson, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 310 Lake St, Warroad, MN 56763 Phone: 218-386-2050 Fax: 218-386-2054 |
News Archive
MD Anderson researchers find significant clinical variations among liver cancer patients
Significant clinical variations exist among patients with the most common type of liver cancer called hepatocellular carcinoma (HCC), depending on the viral cause of the disease -hepatitis B virus (HBV) or hepatitis C virus (HCV). These differences suggest that hepatitis status should be considered when developing treatment plans for newly diagnosed patients, according to researchers at The University of Texas MD Anderson Cancer Center.
Alkermes initiates multidose Phase 1 clinical study of ALKS 37 for OIC
Alkermes, Inc. today announced the initiation of a multidose phase 1 clinical study of ALKS 37, an orally active, peripherally-restricted opioid antagonist with potential to block the effects of opioid agonists on gastrointestinal motility, commonly referred to as opioid-induced constipation (OIC). The randomized, double-blind, placebo-controlled, repeat-dose study will assess the safety, tolerability and pharmacokinetics of daily oral administration of two dose levels of ALKS 37 for a seven day period in approximately 24 healthy volunteers.
An in-depth look at how a Medicaid block grant would work
Kansas Health Institute News published a package of stories detailing how the block grant concept works, the pros and cons of this approach, and the history of such proposals.
Scientists at retrovirus conference present findings on microbicide gel, Truvada, male circumcision, ART care by nurses
At the annual Conference on Retroviruses and Opportunistic Infections (CROI) in Boston on Monday, researchers "suggested the potential" of a gel containing the antiretroviral drug tenofovir to reduce the risk of anal HIV transmission, TIME's "Healthland" blog reports.
New clinical trial uses universal natural killer cell approach to treat acute myeloid leukemia
A new, phase I clinical trial offered The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute will treat patients with relapsed or refractory acute myeloid leukemia using a novel universal natural killer cell approach.
› Verified 6 days ago